ArticleACS medicinal chemistry letters2025

Development of a Highly Potent Neurokinin‑3 Receptor Inhibitor: Design, Synthesis, and Evaluation.

Shengmin Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.